Accelerated Amortized Payment of Convertible Bond Installment
Avacta Appoints Patrick Vink as Deputy Chairman
Avacta Therapeutics (AIM: AVCT) has appointed healthcare executive Dr Patrick Vink to its board as non-executive deputy chairman and senior independent director.
Amaroq moves closer to London Main Market listing
Update on Intention to Move from AIM to Main Market
Avacta advances AVA6000 towards pivotal US trial
Avacta Therapeutics (AIM: AVCT) has secured a significant regulatory milestone after reaching an agreement with the US Food and Drug Administration on the pivotal trial design for its lead cancer
Shareholders give overwhelming support to Avacta proposals
Avacta Group PLC announced that all resolutions were passed at its Annual General Meeting, with overwhelming shareholder support for each proposal.
Avacta Extends Cash Runway as Clinical Pipeline Advances
Avacta Therapeutics (AIM: AVCT) has reported strong progress across its oncology pipeline in the first half of 2026, highlighting advances in both its clinical programmes and balance sheet ahead of
£9m fundraising gives Avacta extra firepower for cancer pipeline
Avacta Therapeutics plc (AIM: AVCT) has strengthened its balance sheet after completing an oversubscribed £9 million equity fundraising, with proceeds earmarked primarily for reducing outstanding convertible bond debt and supporting
Avacta showcases progress in salivary gland cancer study
Avacta Group PLC (AIM: AVCT) unveiled encouraging new clinical data for its lead oncology candidate AVA6000 (faridoxorubicin) at the ASCO 2026 annual meeting, highlighting both promising efficacy and a potentially
Arsenal vs PSG Set for Champions League Final Showdown in Budapest
European football’s biggest prize will be decided on Saturday as Premier League champions Arsenal face Ligue 1 winners Paris Saint-Germain in the UEFA Champions League final at Budapest’s Puskás Arena.
Avacta Therapeutics (AIM: AVCT) Board Director Changes
Avacta Therapeutics (AIM: AVCT) has announced a boardroom transition, with Richard Hughes to be appointed non-executive chairman following the company’s Annual General Meeting on 22 June 2026.
Amaroq documentary highlights race for Greenland’s critical minerals
In 2025, Greenland moved decisively to the centre of the conversation about Western critical mineral supply, Arctic security, and the future of the North Atlantic alliance. Amaroq sits at the
Avacta strengthens cancer treatment story with clinical advances
Avacta Group plc has reported significant progress across its pre|CISION oncology platform in its unaudited preliminary results for the year ended December 31, 2025, as the company advances multiple cancer